Drug intelligence / Profile preview

theaflavin

Development stage
Preclinical
Lead developer
Rutgers University
Modality
Small Molecules
Administration
Oral
01

Overview

Theaflavin is a naturally occurring polyphenolic compound belonging to the biflavonoid class, formed during the oxidation ("fermentation") of catechins in black tea leaves. Its core structure is a benzotropolone derivative, which is responsible for its potent antioxidant activity. Theaflavin displays a range of biological effects including antioxidant, anti-inflammatory, antineoplastic (anticancer), cardiovascular-protective, and antimicrobial actions. Mechanistically, it acts by scavenging free radicals, modulating cellular signaling pathways such as NF-κB and MAPK, and inhibiting pro-inflammatory enzymes like cyclooxygenase and lipoxygenase. It is recognized primarily as a plant metabolite and is not an approved pharmaceutical agent for any indication.

Other names
1,8-Bis((2R,3R)-3,5,7-trihydroxy-2H-1-benzopyran-2-yl)-3,4,6-trihydroxy-5H-benzocyclohepten-5-one3,4,5-trihydroxy-1,8-bis[(2R,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]benzo[7]annulen-6-one3,4,6-trihydroxy-1,8-bis((2R,3R)-3,5,7-trihydroxychroman-2-yl)-5H-benzo[7]annulen-5-onetheaflavineCAS 4670-05-7CAS4670-05-7CAS-4670-05-7UNII 1IA46M0D13UNII1IA46M0D13UNII-1IA46M0D13CHEBI:136609HMDB0005788HMDB-0005788HMDB 0005788Nikkaji Number J277.684G
02

Targets

15-LOX (Lysyl Oxidase)NF-κBCOXMpro (3C-like proteinase of SARS-CoV-2)LTF (Lactoferrin)Sucrase-Isomaltase

Beyond the preview

Go deeper on theaflavin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on theaflavin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call